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Abstract
Low bone mineral density (BMD) is established as a primary predictor of osteoporotic risk and can also have substantial 
implications for athlete health and injury risk in the elite sporting environment. BMD is a highly multi-factorial phenotype 
influenced by diet, hormonal characteristics and physical activity. The interrelationships between such factors, and a strong 
genetic component, suggested to be around 50–85% at various anatomical sites, determine skeletal health throughout life. 
Genome-wide association studies and case–control designs have revealed many loci associated with variation in BMD. How-
ever, a number of the candidate genes identified at these loci have no known associated biological function or have yet to be 
replicated in subsequent investigations. Furthermore, few investigations have considered gene–environment interactions—in 
particular, whether specific genes may be sensitive to mechanical loading from physical activity and the outcome of such an 
interaction for BMD and potential injury risk. Therefore, this review considers the importance of physical activity on BMD, 
genetic associations with BMD and how subsequent investigation requires consideration of the interaction between these 
determinants. Future research using well-defined independent cohorts such as elite athletes, who experience much greater 
mechanical stress than most, to study such phenotypes, can provide a greater understanding of these factors as well as the 
biological underpinnings of such a physiologically “extreme” population. Subsequently, modification of training, exercise 
or rehabilitation programmes based on genetic characteristics could have substantial implications in both the sporting and 
public health domains once the fundamental research has been conducted successfully.
Keywords Genetics · Bone · Exercise · Polymorphism · Running · Fracture
Abbreviations
AXIN1  Axin 1
BMD  Bone mineral density
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RANKL  Receptor activator of nuclear factor κB 
ligand
SFRP4  Secreted frizzled-related protein 4
SNP  Single nucleotide polymorphism
SOST  Sclerostin
STARD3NL  StAR-related lipid transfer domain con-
taining 3 N-terminal like
TNFSF11  TNF receptor superfamily member
TNFRSF11A  TNF receptor superfamily member 11a
TNFRSF11B  TNF receptor superfamily member 11b
VDR  Vitamin D (1,25-dihydroxyvitamin  D3) 
receptor
WNT5B  Wnt family member 5B
WNT16  Wnt family member 16
Introduction
Low bone mineral density (BMD) is established as a pri-
mary predictor of osteoporotic risk and can have substantial 
implications for athlete health and injury risk in the elite 
sporting environment. BMD is a highly multi-factorial 
phenotype influenced by diet, hormonal characteristics as 
well as physical activity (Darling et al. 2009; Pluijm et al. 
2001). Physical activity/exercise reportedly accounts for 
up to 30% of the variability in BMD (Valdimarsson et al. 
1999) although the exact contribution of physical activ-
ity to BMD remains unclear and requires further explora-
tion across various population groups. Following physical 
activity, osteocytes detect shape and volume changes to 
increase or decrease the liberation of specific bone media-
tors, which consequently influences bone formation and 
resorption (Nakashima et al. 2011). Consequently, athletic 
populations tend to possess higher BMD than non-athlete 
counterparts. Training and competition in weight-bearing 
sports that comprise high strain rates and peak-force load-
ing characteristics on bone result in enhanced total or site-
specific BMD as shown across a number of sports (Torstveit 
and Sundgot-Borgen 2005). This principle, however, can be 
more complex in sports that are associated with low body 
mass or reduced energy availability, such as endurance run-
ning, where low BMD and stress fractures can be observed 
(Pollock et al. 2010; Loucks 2007). Additionally, the volume 
of physical activity completed in childhood and the age at 
which an athlete may have started their sport may also have 
implications for BMD across the lifespan. Generally, child-
hood and the pre-pubertal years are considered a key period 
for bone accretion (Weaver et al. 2016). A large volume of 
research into the effect of physical activity on BMD and/
or osteoporosis has been completed although limited inves-
tigations exist regarding certain athletic populations such 
as endurance runners. Moreover, many studies have used 
questionnaires to assess physical activity level, which can 
lack accuracy or reliability (Prince et al. 2008) and thus, the 
exact contribution of physical activity remains unclear and 
requires further exploration across population groups.
A large genetic component to BMD also exists, with 
heritability of BMD suggested to be 50–85% depend-
ing upon anatomical location (Ralston and Uitterlinden 
2010). Knowing the genetic variants associated with BMD 
could have substantial implications for future research, as 
well as application and rehabilitation management in both 
the public health domain and elite sporting environment. 
For example, accuracy of fracture risk classification was 
improved by 7–10% in osteopenic patients by adding an 
early genetic risk score (Lee et al. 2014) whilst modify-
ing training programmes based on genetic characteristics 
reduced injury rates in endurance athletes (Goodlin et al. 
2015). Practical application using genetics, however, is cur-
rently very restricted due to limited evidence on proposed 
candidate genes associated with BMD. Over 66 genetic loci 
have been associated with dual-energy X-ray absorptiometry 
(DXA)-derived BMD or fracture via genome-wide associa-
tion studies (GWAS) thus far (Hsu and Kiel 2012; Estrada 
et  al. 2012) and this number will continue to increase. 
Additionally, many of the previously discovered candidate 
genes have had little or no replication through further study, 
which means only a very small number can be confidently 
suggested to have an association with BMD (Hsu and Kiel 
2012). The biological function or involvement with bone 
metabolism of 30 of these has also yet to be elucidated and 
only seven of the 66 have been associated in candidate gene 
studies previously or positively replicated afterwards (Hsu 
and Kiel 2012) although some have received no further study 
as of yet. Studies so far have only elucidated a fraction of 
BMD variance and thus, some of the unexplained heritabil-
ity is likely due to a number of factors such as gene–environ-
ment interactions (Ackert-Bicknell and Karasik 2013). This 
could apply most strongly to certain populations such as 
athletes, due to the substantial influence of physical activity 
on BMD and a likely gene–mechanical loading interaction.
The genetic influence on BMD and the relationship 
with physical activity has not been explored extensively. 
In vitro studies have shown substantial alteration in gene 
expression following mechanical loading (Mantila Roosa 
et al. 2011), whilst a small number of candidate genes have 
reported physical activity interactions in children (Mitch-
ell et al. 2016). A small number of investigations have also 
been completed in athletic populations across a number of 
different bone phenotypes. For example, higher total BMD 
in weight-bearing athletes than controls was observed in 
the FF (7.7%) and Ff (6.9%) but not ff (1.8%) genotypes of 
the vitamin D (1,25-dihydroxyvitamin  D3) receptor (VDR) 
FokI rs2228570 polymorphism, whilst lower total BMD was 
only observed in the FF (− 4.5%) genotype when comparing 
swimmers with a control group (Nakamura et al. 2002b). 
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Additionally, variants in the purinergic receptor P2X7 
(P2RX7), human TNF receptor superfamily member 11a 
(TNFRSF11A) and sclerostin (SOST) genes have been asso-
ciated with stress fracture in elite athletes (Varley et al. 2015, 
2016, 2017). Substantial further study is needed on candi-
date genes associated with BMD and other phenotypes such 
as stress fracture, as well as greater exploration of genes that 
may interact with physical activity and the implications this 
would have for BMD and wider application in public health 
and elite sport.
Therefore, the aims of this narrative review are to (1) 
provide a critical review of the current literature on the influ-
ence of physical activity on BMD, particularly in athletic 
populations such as endurance runners; (2) provide an over-
view of genetic associations with BMD and highlight studies 
that have assessed this association in athletic populations; 
and (3) explore gene–BMD–physical activity interactions 
and identify future applications these might have in both the 
public health domain and elite sporting environment.
Bone mineral density (BMD)
Peak bone mass is a function of bone size and volumetric 
BMD (Leonard and Bachrach 2012) and thus, is the amount 
of bony tissue present following skeletal maturation, which 
can have a substantial influence on osteoporotic risk in later 
life (Bonjour et al. 1994). BMD is defined as the ratio of 
mass to the area or volume of bone, which is known as areal 
(g/cm2) or volumetric (g/cm3) BMD, depending upon the 
measurement methodology used (Ott et al. 1997). BMD is 
considered the primary predictor of osteoporotic fracture, 
although it is important to note other factors when assess-
ing clinical risk (Cranney et al. 2007). BMD accounts for 
60–65% of the variance in bone strength so other factors 
such as bone geometry, collagen properties as well as tra-
becular and cortical microarchitecture are also important 
determinants of bone strength (Schoenau et al. 2002; Fon-
seca et al. 2014; Cheung et al. 2016).
Bone mass is regulated by the activity of osteocytes in 
response to a number of stimuli, such as disuse, matrix dam-
age or hormone deficiency (Atkins and Findlay 2012) and 
the actions of osteoblasts and osteoclasts, which are impor-
tant for bone formation and resorption. Disproportionate 
activity rates of these bone cells, for instance, greater net 
osteoclastic than osteoblastic activity, can cause bone loss, 
as observed in ageing (Martin and Sims 2005). Approxi-
mately 85–95% of peak bone mass is attained around late 
adolescence (Henry et al. 2004; Walsh et al. 2009). After 
peak bone mass is reached, BMD loss occurs as we age 
(Fig. 1) and the rate of loss plays an important role in bone 
health and the development of related conditions, such as 
osteoporosis (Hernandez et al. 2003). BMD deterioration 
varies between individuals as well as anatomical sites, with 
yearly rates of decline after the age of 25 years at the distal 
radius, distal tibia and lumbar spine reportedly 0.40%, 0.24% 
and 1.61%, in women and 0.38%, 0.40% and 0.84%, in men. 
Additionally, men and women experience 42% and 37% of 
trabecular bone loss as well as 15% and 6% of cortical bone 
loss before the age of 50 years (Riggs et al. 2008). Similar to 
the ability to enhance peak BMD with lifestyle choices, it is 
possible to slow the inevitable decline in BMD with ageing 
using preventative measures via lifestyle modification. Some 
of these factors include not smoking (Law and Hackshaw 
1997), maintaining a healthy dietary intake (Darling et al. 
2009) and relatively high physical activity level (Pluijm et al. 
2001; Krall and Dawson-Hughes 1993).
BMD and physical activity
Quantifying the relative contributions of physical activity 
and other determinants to BMD remains difficult. Exercise/
physical activity reportedly accounts for up to 30% of the 
variability in total BMD (Table 1), emphasising that the 
contribution of physical activity to BMD remains unclear 
and requires further exploration across various population 
groups.
Initially proposed by Wolff’s law and Frost’s mechanostat 
theory, bone adapts or remodels in response to the forces or 
demands placed upon it (Frost 1990). This mechanotrans-
duction is completed through four steps: mechanocoupling, 
biochemical coupling, signal transmission and effector cell 
response (Duncan and Turner 1995). Bone metabolism is 
regulated via specific pathways, such as the receptor activa-
tor of nuclear factor κB/receptor activator of nuclear factor 
κB ligand/osteoprotegerin (RANK/RANKL/OPG), Wnt sig-
nalling and purinergic signalling pathways, through initia-
tion of osteoblastic or osteoclastic activity (Tyrovola and 
Odont 2015). Following physical activity, osteocytes detect 
shape and volume changes to increase or decrease the libera-
tion of these bone mediators, which consequently influences 
bone formation and resorption (Nakashima et al. 2011). This 
notion has been observed in numerous populations including 
children, adults and older adults, with those who complete a 
large volume of physical activity/exercise possessing greater 
BMD, strength and muscle mass (Chilibeck et al. 1995; Sle-
menda et al. 1991; Beck and Snow 2003; Warburton et al. 
2006). The point in time when this physical activity occurs 
may also influence bone development and bone mass, poten-
tially resulting in lifetime benefits for skeletal health (Gunter 
et al. 2012). Generally, weight-bearing activity in childhood 
has been shown to increase total body BMD in adolescents 
and children (Weeks et al. 2008; Heidemann et al. 2013), as 
well as demonstrate a continued benefit into adulthood at key 
sites such as the femoral neck and lumbar spine (Strope et al. 
2015). Tveit et al. (2013) reported that exercise-associated 
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high BMD in 46 young male athletes (mean age = 22 years) 
was preserved three decades after retirement and cessation 
of high volumes of physical activity. Similarly, ex-profes-
sional baseball players in their ninth decade of life retained 
more than half of the throwing-related benefits in bone size 
and a third of the throwing-related benefits in bone strength 
observed in current professionals (Warden et al. 2014).
Some studies have suggested that activity completed in 
the pre-pubertal stage is the most favourable to instigate 
bone development due to the elevated levels of growth hor-
mone present at this time (Bass et al. 1998). Growing bone 
has an enhanced capability to respond to increased mechani-
cal loading and thus initiate greater structural adaptations 
to this stimulus, compared to adult bone (Bass et al. 1998). 
This notion of an optimal period or “window of opportunity” 
for exercise-induced bone development could be important 
in improving bone health by maximising peak bone mass 
attainment during this time (Bass et al. 1998) and therefore, 
delaying the onset of age- or menopause-related osteoporosis 
(Santos et al. 2017). Despite this, Behringer et al. (2014) 
completed a meta-analysis suggesting that weight-bearing 
activities in childhood and adolescence had no significant 
influence on BMD in adulthood. The authors based their 
conclusion, however, on 27 studies out of a possible 109 
completed before 2012 and suggest their findings might have 
been skewed as a result. Therefore, the overall consensus, as 
outlined by the National Osteoporosis Foundation’s recent 
position statement, is that the best evidence suggests a posi-
tive effect of physical activity during late childhood and 
Fig. 1  Schematic representation 
of typical age- and sex-related 
loss of BMD in men and women
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Table 1  Contribution of physical activity to BMD
Population BMD determinant Variability in BMD References
Icelandic women
aged 16–20 years
Lean mass and physical exercise 30% Valdimarsson et al. (1999)
Men and women
aged 20–25 years
Sports activities 10.4%—men
< 1%—women
Neville et al. (2002)
Pre-menopausal women
aged 35–37 years
Member of sports club completing 
persistent weight-bearing activity 
in adulthood
5–19% Barnekow-Bergkvist et al. (2006)
European Caucasian men
aged 65–80 years
High-impact unilateral training 
programme on one leg (EL) in 
comparison with the other leg 
(CL)
1.6% net gain in femoral neck 
between EL and CL
Allison et al. (2015)
Men and women
aged 20–54 years
Physical activity level Active women and men had 
2.7–4.6% and 1.9–3.0% higher 
BMD, respectively, than seden-
tary counterparts
Morseth et al. (2010)
Men
aged 17–20 years
Physical activity habits 10.1% Pettersson et al. (2010)
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pre-pubertal years and this is a key period for bone accre-
tion (Weaver et al. 2016).
The ability to complete studies that are both longitudinal 
and valid accounting for accurate measurement of activity 
(i.e. quantifying intensity in relation to the bone-loading 
forces experienced) is extremely problematic. Many inves-
tigations have used self-report activity questionnaires rather 
than more direct measurements, such as via accelerometers 
or pedometers (Ondrak and Morgan 2007). Self-report ques-
tionnaires rely upon recall and response bias; correlations 
between self-report and direct measurement of physical 
activity have been reported as low-to-moderate, ranging 
from − 0.71 to 0.96 (Prince et al. 2008). Whilst accelerom-
eters are capable of objectively quantifying activity level, 
this is still an estimation limited by validity, reliability 
and calibration concerns (Troiano et al. 2014) as well as 
being unable to provide direct measurement of the stimulus 
applied to any particular bone or the skeleton as a whole. 
Furthermore, there has been much methodological variance 
in studies exploring this topic, such as participant character-
istics and sample size, the differing methods used to meas-
ure physical activity and types of physical activity/exercise 
completed in the training intervention. These factors make it 
difficult to draw conclusions on the exact influence of physi-
cal activity on BMD and may explain the large variability 
in the extent of the skeletal response to loading reported in 
intervention studies. For reviews on this topic, see Warbur-
ton et al. (2006) and Ondrak and Morgan (2007).
Quantifying the optimum amount of physical activity 
for bone health is both difficult and complex when consid-
ering all of the potential confounding variables. Research 
has suggested that the current US Department of Health 
and Human Services and UK Chief Medical Office physi-
cal activity guidelines do not allow maximisation of BMD 
potential (Whitfield et al. 2015). Additionally, the type of 
physical activity may also be important for optimising BMD. 
Habitual levels of high, but not moderate or light, physi-
cal activity was positively related to BMD in adolescents 
(Deere et al. 2012) as well as in older adults (Hannam et al. 
2017). However, high impacts in adolescents were classed as 
> 4.0g but only > 1.5g in the older adults. Thus, the impact 
threshold required to combat bone loss is likely to be lower 
in older adults but higher g forces may be required to stimu-
late acquisition during peak attainment in childhood (Tobias 
2014), which adds further complexities to understanding the 
influence of physical activity on bone health. Therefore, due 
to the difficulty of quantifying physical activity and the large 
number of determinants of BMD, investigating the influence 
or association of physical activity on BMD is challenging. 
Using homogenous cohorts that are known to be undertaking 
similar amounts of physical activity, such as athletic popula-
tions, can somewhat alleviate this issue.
BMD in athletic populations
Physical activity can be defined as any movement imple-
mented by skeletal muscle that results in energy expenditure, 
whereas exercise refers to physical activity that is planned, 
structured and repetitive with an aim to maintain or improve 
a physical fitness component (Caspersen et al. 1985). There-
fore, athletic populations who complete large volumes of 
exercise also tend to possess higher BMD and bone mass 
than non-athletic individuals via the loading adaptation 
mechanisms mentioned above (Chilibeck et al. 1995). How-
ever, the loading characteristics of different sports vary, thus 
the BMD of athletes partaking different sports or disciplines 
also varies, particularly between different anatomical sites 
(Mudd et al. 2007; Bennell et al. 1997). One of the earli-
est applied studies investigating BMD of athletes compet-
ing in different sports showed significantly higher total and 
site-specific BMD in volleyball players in comparison with 
gymnasts, swimmers and non-athletic controls, although 
the BMD of the gymnasts was significantly higher than the 
other two groups (Fehling et al. 1995). This emphasises that 
physical activity/exercise, which expresses higher impacts 
through increased strain rates and high peak-force loading 
characteristics, as can be expected of volleyball players, 
results in enhanced total or site-specific BMD as shown 
across of a number of sports (Table 2).
In endurance runners specifically, most studies have 
shown a higher BMD than control populations, particu-
larly at the primary loading sites (tibia, femoral neck, 
calcaneus), although this is not always the case due to 
other variables, such as low energy availability (Scofield 
and Hecht 2012). However, endurance runners tend to 
have lower BMD than athletes from other weight-bear-
ing sports, such as sprinters or gymnasts, where forces 
applied to bone are more likely to be varied in magnitude 
and directions (Scofield and Hecht 2012). Master athletes 
over the age of 65 years who are still competing in run-
ning events have been shown to possess higher BMD than 
non-active counterparts (Velez et al. 2008). Furthermore, 
former elite runners, soccer players and weightlifters have 
been shown to possess higher BMD than non-active con-
trols as well as suffer osteoporotic hip fractures at a signifi-
cantly older age (Kettunen et al. 2010). This emphasises 
the potential of BMD to be maintained and the impor-
tance of weight-bearing exercise in contributing to skeletal 
integrity in later life.
Studying athletes who experience extreme amounts of 
loading can somewhat compensate for the aforementioned 
limitations associated with quantifying physical activity. 
Elite athletes in weight-bearing sports are a unique popula-
tion who generally experience extreme amounts of mechani-
cal loading, which, although not a perfect solution, presents 
an attractive model for future research studies hoping to 
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investigate the impact of exercise on BMD. Additionally, by 
selecting homogeneous athlete groups, who compete in the 
same event to a similar standard, it would be reasonable to 
assume these individuals undertake similar training regimes/
volumes. For instance, Billat et al. (2001) reported high-
level male marathon runners with a personal best of < 2 h 
16 min ran an average weekly distance of 168 km (± 20 km) 
and females with a personal best of < 2 h 36 min completed 
150 km (± 17 km) on average.
BMD, elite athletes and injury risk
Despite the benefits of weight-bearing activity for BMD, 
at the elite sporting level, too much activity to the point of 
overtraining can result in negative outcomes (Kuipers and 
Keizer 1988). A stress fracture would be one such outcome 
and is defined as a partial or complete fracture of bone from 
repeated application of force lower than that required to frac-
ture a bone in a single loading (Iwamoto and Takeda 2003). 
Stress fracture injury occurs due to the repetitive mechanical 
loading that stimulates an incomplete remodelling response 
(Jones et al. 2002) and several factors are known to influence 
an individual’s susceptibility to experience a stress fracture 
(Bennell et al. 1999). Such factors include biomechanical 
gait (Milner et al. 2006), bone size and mechanical prop-
erties (Tommasini et al. 2005), nutritional factors (Nieves 
et al. 2010), training volume and rapid increments in volume 
(Snyder et al. 2006), small musculature and low BMD (Beck 
et al. 2000).
Unsurprisingly, higher incidence of lower limb stress 
fractures is observed in endurance runners in compari-
son with non-athletic controls. Significant amounts of 
site-specific loading combined with other factors typi-
cal of this group, such as low energy availability, can 
result in lower BMD and a higher risk of fracture occur-
rence (Loucks 2007). Stress fractures reportedly account 
for 50% of all injuries sustained by runners and military 
recruits, with higher incidence observed in females (Mil-
ner et al. 2006). However, there is a lack of research on 
stress fractures in running populations (Wright et  al. 
2015). Although lower BMD has been observed at the 
foot in female athletes with a history of stress fracture, 
compared to those without, this was accompanied by 
lower lean mass, leg-length discrepancy and fewer men-
strual cycles per year, which may be influential (Bennell 
et al. 1996). Furthermore, determining accurate preva-
lence is also difficult due to the problematic nature of 
defining stress fractures. Significant misdiagnosis will 
occur unless limited to radiography, although this can 
still lack sensitivity and specificity (Wright et al. 2016).
Investigating BMD, with a particular emphasis on 
injury, is undoubtedly important because stress fractures 
have substantial implications for athletes. For instance, 
Marathon world record holder, Paula Radcliffe, report-
edly suffered a stress fracture 3  months before the 
Table 2  BMD variation across different sports
Population Sport BMD variation References
300 Norwegian female elite athletes 
(national level at senior or junior)
300 non-athletic controls
66 sports 3–20% higher BMD than controls. 3–22% higher BMD 
in high-impact sports compared to medium- or low-
impact sports
Torstveit and Sund-
got-Borgen (2005)
15 elite male athletes
15 non-athletic controls
Volleyball 14% and 24% higher BMD at the lumbar spine and 
femoral neck, respectively, in volleyball players in 
comparison with non-athletic controls
Calbet et al. (1999)
14 state-level female athletes
18 non-athletic controls
Netball 7.8%, 17.3% and 14% higher total body, hip and lumbar 
spine BMD in the netballers in comparison with the 
controls
Chang et al. (2013)
50 male highly trained athletes
12 non-athletic controls
12 judokas
14 karate athletes
24 water polo players
Control group total body BMD (1.27 g/cm2) was sig-
nificantly lower than the judo (1.40 g/cm2) and karate 
(1.36 g/cm2) group but no different to the water polo 
athletes (1.31 g/cm2)
Andreoli et al. (2001)
59 competitive Finnish female athletes
25 physical active individuals
25 sedentary individuals
27 dancers
18 squash players
14 speed skaters
Squash players had significantly higher BMD at the 
lumbar spine (13%), femoral neck (16.8%), proximal 
tibia (12.6%) and calcaneus (18.5%) in comparison 
with the sedentary group. Aerobic dancers also had 
significantly higher BMD at the loaded sites in com-
parison with the sedentary group, ranging from 5.3 to 
13.5%
Heinonen et al. (1995)
60 athletes
15 non-athletic controls
15 runners
15 swimmers
15 triathletes
15 cyclists
Runners had significantly higher total body, femoral 
neck and leg BMD than controls and swimmers as 
well as higher leg BMD than cyclists
Duncan et al. (2002)
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Beijing 2008 Olympics, limiting her preparation for and 
performance at that competition. Furthermore, Ranson 
et al. (2010) reported 43% of the elite fast bowlers they 
investigated developed symptomatic acute lumbar stress 
fractures in a 2-year follow-up period and subsequently 
missed 169 days of cricket, per episode, on average.
If athletes are unable to complete their desired or 
required training volume due to injury, this could have 
substantial negative effects on their performance and 
success. Additionally, if an athlete knows they may be 
susceptible to injury, this could be accounted for in their 
training programmes, by placing a greater emphasis 
on appropriate strengthening exercises and/or allow-
ing longer rest periods between sessions. This valuable 
information for tailored training could then ultimately 
influence progression of athletes from amateur to elite 
or have implications for selection into high-level teams 
or sporting competitions. It is apparent that a substantial 
proportion of research in this area has been completed in 
military recruits (Wright et al. 2015). This is probably 
due to the ease of accessing large samples who undertake 
a quantifiable training load, as well as a desire to mini-
mise waste of human and financial resources caused by 
injuries. However, it is difficult to directly extrapolate the 
findings of these military studies to elite runners due to 
differences in the level of physical fitness, footwear and 
the loads carried whilst running between these groups. 
Despite possible stress fractures, the positive benefits of 
physical activity/exercise on BMD in a broad population 
are evident. As discussed, there are a number of deter-
minants influencing BMD but relatively little is known 
about the genetic influence on this phenotype and stress 
fractures, which could be pivotal for future understanding 
in both the sporting and public health domains.
Genetic association with BMD
Although BMD is a multi-factorial phenotype, heritabil-
ity of BMD is suggested to be 50–85% depending upon 
anatomical location (Ralston and Uitterlinden 2010). 
However, it must be emphasised that this proposed large 
genetic component is in a free-living population where 
most people will not complete extreme volumes of physi-
cal activity or be severely malnourished and thus, the 
influence of these other environmental factors on BMD 
will be reduced. Therefore, even a very substantial genetic 
contribution to BMD does not mean physical activity or 
other factors cannot notably affect an individual’s BMD 
(as shown in “BMD and physical activity”).
Due to this substantial genetic component, knowing 
the associated variants could be extremely beneficial for 
both functional research focus as well as application. 
For example, accuracy of fracture risk classification was 
improved by 7–10% at various sites in osteopenic patients 
by adding a genetic risk score from proposed common or 
rare variants associated with BMD and/or osteoporosis 
(Lee et al. 2014). In the future, this application might be 
utilised in athletic populations for risk stratification and 
injury prevention. However, utilising a genetic risk score 
with elite athletes is currently difficult due to a lack of 
known candidate genes associated with BMD in athletic 
populations, which emphasises the need for replication of 
potential candidate genes and specific studies on particu-
lar populations, who may possess high or low BMD, or 
demonstrate specific lifestyle choices/habits that influence 
BMD.
Beginning in clinical populations, studies that selected 
candidate genes for association with BMD due to known 
biological function, such as VDR, insulin-like growth fac-
tor 1 (IGF1) and oestrogen receptor 1 (ESR1) (Gong and 
Haynatzki 2003), produced inconclusive findings. Can-
didate gene selection can be based on the premise that 
the protein plays a role in regulating bone cell function 
or calcium metabolism (Ralston and de Crombrugghe 
2006), and the differing variants may affect bone media-
tors and consequently influence BMD. For example (as 
highlighted in Fig. 2 below), the human TNF receptor 
superfamily member 11b (TNFRSF11B) gene encodes 
the protein osteoprotegerin (OPG), which regulates bone 
resorption by inhibiting differentiation and activation 
of osteoclasts. OPG-deficient mice have been found to 
develop early-onset osteoporosis, and increased tissue 
mRNA expression has been observed in participants who 
possess specific haplotypes accompanied with reduced 
BMD, which may be due to increased expression result-
ing in stimulated osteoclast activity (Takács et al. 2010). 
This simplistic model forms the basis of genetic regula-
tion on BMD but, in reality, the process is much more 
complex due to environmental factors and various kinds of 
interactions, which could have a substantial effect on gene 
expression and phenotype outcome. This potential impact 
of mechanical loading on gene expression can be under-
stood by the substantial upregulation and downregulation 
of numerous genes following mechanical loading in rats 
(Mantila Roosa et al. 2011). Genes including FOS-like 1, 
AP-1 transcription factor subunit (FOSL1) and JunB proto-
oncogene, AP-1 transcription factor subunit (JUNB) were 
both upregulated within 4 h after loading, whilst expres-
sion of Wnt/β-catenin signaling genes SOST and secreted 
frizzled-related protein 4 (SFRP4) was also altered in the 
synthetic phase of bone formation (Mantila Roosa et al. 
2011). In the case of OPG, in vitro evidence demonstrated 
that compressive forces increase IL-6 and  PGE2 produc-
tion through the activation of intracellular calcium/extra-
cellular signal-regulated kinase 1/2 and nuclear factor-κB 
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translocation (Ca++/ERK1/2/NF-κB) signalling pathways, 
which results in decreased osteoblast OPG expression (and 
a decreased OPG/RANKL ratio) and enhanced matrix met-
allopeptidase (MMP) production, consequently increasing 
bone resorption (Sanchez et al. 2009).
Recent technological advances and large collaborations 
have seen a number of genome-wide association studies 
(GWAS) with BMD completed, which identified many more 
potential candidate genes and SNPs (Richards et al. 2012; 
Clark and Duncan 2015). However, the most prominent 
study to date, a meta-analysis conducted by Estrada et al. 
(2012), identified 56 loci associated with BMD, osteopo-
rosis and/or fracture that accounted for ~ 6% of the varia-
tion in BMD. Overall, more than 66 genetic loci have been 
associated with (DXA derived) BMD via GWAS method, 
as well as many others through candidate gene association 
studies, and this number continues to increase, emphasis-
ing the extremely polygenic nature of BMD (Golchin et al. 
2016). A further 153 loci have been associated with BMD 
estimated by quantitative ultrasound of the heel (Kemp et al. 
2017). A specific recent addition, for instance, is a locus 
harbouring the Patched 1 (PTCH1) gene in an Icelandic 
population (Styrkarsdottir et al. 2016). This rapid discovery 
rate of new candidate genes and the fact many previously 
discovered candidate genes have had little or no replication 
through further study means only a very small number can 
be confidently suggested to have an association with BMD. 
Furthermore, the biological function or involvement with 
bone metabolism of 30 of these has yet to be elucidated and 
only 7 of the 66 have been associated in candidate gene stud-
ies previously or positively replicated afterwards (Hsu and 
Kiel 2012) although some have received no further study as 
of yet. To have only seven candidate genes positively associ-
ated through both methods so far is surprising, considering 
almost 100 different loci have been associated with BMD 
via a candidate gene approach (Hsu and Kiel 2012). Hsu 
and Kiel (2012) suggested a number of reasons why this 
may have occurred; first, false-negative findings due to the 
stringent level of statistical significance typically applied to 
GWAS data, or inadequate statistical power in some studies 
that were unable to replicate associations with modest effect 
sizes. On the other hand, false-positive findings of candidate 
gene association studies may have prevailed due to small 
sample sizes or publication bias (Munafo et al. 2004).
Additionally, strong gene–gene or gene–environment 
interactions could alter the number and identity of loci asso-
ciated with BMD. This could apply to specific populations, 
such as athletes, due to the substantial influence of physical 
activity on BMD. Ultimately, this has resulted in few candi-
date genes emerging from GWAS and/or association studies 
that also have a known biological function relevant to bone. 
Therefore, further research using well-defined independ-
ent cohorts is needed to provide further evidence (Agueda 
et al. 2010). Clark and Duncan (2015) suggest greater use 
of “extreme cohorts” who might possess variants that have 
stronger associations with relevant phenotypes, which could 
include elite athletes at one end of a continuum (as men-
tioned in “BMD in athletic populations”) and osteoporotic 
individuals at the other. This approach has been applied to 
BMD successfully in a study of postmenopausal women 
with extremely high or low BMD, where GWAS revealed 
six novel genetic associations (Duncan et al. 2011).
Studies so far have only elucidated a small fraction of 
BMD variance and thus some of the unexplained heritability 
is likely due to a number of factors, including gene–envi-
ronment interactions (Ackert-Bicknell and Karasik 2013). 
Despite the substantial effect of physical activity/exercise on 
BMD, there has been little research regarding gene–physi-
cal activity interactions and its effects on BMD in athletic 
populations. Therefore, this limited amount of research, as 
well as the variance in sample size and participant charac-
teristics, means it is difficult to evaluate the extent of the 
gene–physical activity interaction with BMD or propose 
any definitive candidate genes that interact with environ-
mental factors in determining BMD. However, looking at 
this relationship using specific cohorts or populations is 
gathering momentum—for example, investigations explor-
ing interactions with others phenotypes, including obesity, 
are now being conducted (Marti et al. 2008). As mentioned 
previously (“BMD in athletic populations”), athletes would 
Fig. 2  TNFRSF11B genotype 
influence on OPG availability 
and subsequent bone formation 
with the potential of environ-
mental and interaction effects
          Environmental factors/gene-gene interactions/gene-environment interactions 
TNFRSF11B genotype 1 >>>>>>  OPG protein available  >>>>>> increased bone formation 
TNFRSF11B genotype 2 >>>>>>       OPG deficiency      >>>>>> decreased bone formation 
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be an excellent sample group to explore this interaction as 
they present an extreme cohort regarding exercise under-
taken and BMD.
Genetic association with BMD and the relationship 
with physical activity
Mitchell et al. (2016) were the first to investigate the genetic 
influence on BMD and the relationship with physical activ-
ity using SNPs that had been associated with BMD using 
GWAS (Estrada et al. 2012). Analysis revealed physical 
activity interacted with ELKS/Rab6-interacting/CAST 
family member 1/Wnt family member 5B (ERC1/WNT5B) 
rs2887571 to influence bone mineral content in males 
and nominal interactions with physical activity were also 
observed with Wnt family member 16 (WNT16) rs3801387, 
axin 1 (AXIN1) rs9921222, SOST rs4792909 and stAR-
related lipid transfer domain containing 3N-terminal-like 
(STARD3NL) rs6959212. Sclerostin has a negative effect 
on bone formation by inhibiting canonical Wnt signalling 
in osteoblasts and also stimulates osteoclastic bone resorp-
tion by increasing the RANKL/OPG ratio (via enhanced 
RANKL expression) (Appelman-Dijkstra and Papapoulos 
2016). Despite this strong influence on bone metabolism, 
conflicting results regarding SOST variants and association 
with BMD have been reported in the literature (Sharma et al. 
2015). Additionally, serum sclerostin concentration has been 
positively correlated with lumbar spine, femoral neck and 
total hip BMD but no variants were associated with BMD 
or sclerostin concentration (He et al. 2014). It is important 
to note that children/young adults (age 5–19 years) were the 
investigated cohort in the Mitchell et al. (2016) study. It is 
suggested that some BMD-associated loci may exert age-
specific effects (Medina-Gomez et al. 2012), and thus the 
findings cannot be generalised to other populations.
Interesting findings have also been reported in candidate 
gene association studies. Kiel et al. (2007) discovered two 
SNPs in the LDL receptor-related protein 5 (LRP5) gene 
associated with differences in BMD, which were depend-
ent upon volume of physical activity completed. The TT 
genotype of both the rs3736228 and rs2396862 SNPs was 
associated with lower BMD in more physically active men, 
but with higher BMD in less physically active men. Thus, 
the authors hypothesised that the substitution of a C with 
a T allele in the rs3736228 SNP could alter LRP5-medi-
ated Wnt signalling in the case that the catabolic signals 
induced from the mechanical loading prevail over anabolic 
signalling. This was also the case when expressing alleles 
as a haplotype in vitro, where the T allele was associated 
with a decreased response to canonical Wnt3a signalling 
in comparison to the C allele. Activation of Wnt/β-catenin 
(canonical) signaling increases the sensitivity of osteoblasts 
to mechanical loading, which can occur via Wnt binding to 
low-density lipoprotein receptor-related proteins 5 and 6 co-
receptors (Robinson et al. 2006; Krishnan et al. 2006). This 
mediation of Wnt signaling via different LRP5 variants can 
both enhance and decrease BMD (Ferrari et al. 2005). Loss-
of-function mutations in LRP5 are also responsible for low 
bone mass disorders, such as osteoporosis pseudoglioma, 
whereas gain-of-function mutations have been suggested to 
cause high bone mass syndromes (Levasseur et al. 2005). 
Furthermore, LRP5 variants, such as C135242T, have been 
associated with BMD variability in the general population 
(Koay et al. 2004) and ds2306862 in osteoporotic individu-
als (Mizuguchi et al. 2004), which highlights the strong 
influence LRP5 may have on bone metabolism, particularly 
when considering a mechanical loading interaction.
Similar to some LRP5 variants, the catechol-O-meth-
yltransferase (COMT) val158met (rs4680) SNP has been 
reported to influence the association between physical activ-
ity and BMD suggesting that certain variants may be par-
ticularly important for BMD in individuals with low physical 
activity levels. Higher total BMD was observed in individ-
uals completing greater levels of physical activity (> 4 h) 
compared to those undertaking lower activity (< 4 h) for GA 
and AA (lower enzyme activity) but not GG (higher enzyme 
activity) genotypes (Lorentzon et al. 2007). Although lower 
BMD was observed in the lower enzyme activity group, 
estradiol serum levels were not. COMT catalyses the methyl-
ation of catechol oestrogens to methoxy oestrogens (inactive 
metabolites) and thus lower COMT enzyme activity should 
result in less efficient inactivation of catechol oestrogens and 
higher BMD in these genotypes as has been shown in other 
studies (Eriksson et al. 2005). Therefore, a COMT genotype 
interaction may be present and the potential regulation of 
the BMD response to mechanical loading may be due to the 
involvement of oestrogen receptors as facilitators in a num-
ber of key pathways by which mechanical strain stimulates 
bone formation (Galea et al. 2013).
Interleukin 6 (IL6) is another potential candidate gene 
with a number of functional polymorphisms, suggested 
as candidates associated with BMD and/or osteoporosis. 
Meta-analysis revealed an association between the GG 
genotype in the IL6 − 174G/C (rs1800795) polymorphism 
and low BMD, as well as increased risk of osteoporosis, in 
a Caucasian population (Ni et al. 2014). In the − 634C/G 
(rs1800796) polymorphism, the CC genotype was associ-
ated with greater BMD in Chinese pre-menarche girls who 
completed higher levels of physical activity (Li et al. 2008). 
Similarly, total body, lumbar spine and femoral neck BMD 
were lower in the GG genotype compared to the CC geno-
type by 0.03, 0.03 and 0.01 g/cm2, respectively, in an Asian 
population (n = 3068) following meta-analysis (Yan et al. 
2015). IL-6 is primarily sourced in osteoblastic cells and 
increases interactions between osteoblasts and osteoclasts, 
thus stimulating bone resorption (Steeve et al. 2004). IL-6 
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is suggested to indirectly stimulate osteoclastogenesis by 
increasing RANKL gene expression in osteoblasts (Bakker 
and Jaspers 2015) and the G allele has been associated with 
elevated production and secretion of IL-6 in vitro (Kitamura 
et al. 2002). Therefore, the G allele and thus elevated IL-6 
may be disadvantageous for bone density. Although there 
are limitations regarding control of other BMD-influencing 
variables and various cohorts used in these studies, IL6 
remains interesting, particularly when analysing a possible 
relationship with physical activity. In vitro studies have sug-
gested IL-6 is produced by shear-loaded osteocytes and may 
influence bone mass by osteocytes reducing osteoblast activ-
ity via IL-6-mediated intercellular signalling (Bakker et al. 
2014). Elevated IL-6 serum concentrations have also been 
observed in trained marathon runners immediately post-race, 
with a positive correlation between IL-6 concentration and 
running intensity (Ostrowski et al. 2000). In longitudinal 
studies, serum IL-6 concentration has been negatively 
associated with bone resorption and BMD in older adults 
although the literature is somewhat conflicting (Ding et al. 
2008). IL6 demonstrates the possibility of strong gene–envi-
ronment interactions and studies that do not control for phys-
ical activity risk erroneous findings and/or results that are 
only applicable to limited portions of the population.
Overall, completing weight-bearing physical activity 
has been shown to increase BMD as discussed in “BMD 
and physical activity”. The effect of potential gene–physi-
cal activity interactions on BMD across the lifespan, how-
ever, has yet to be determined. It could be hypothesised that 
if an individual has a disadvantageous genetic profile and 
completes low levels of weight-bearing physical activity, 
they may be at risk for low BMD and potentially osteopo-
rosis in later life (Disadvantageous TGS and low levels of 
PA) (Figs. 3 and 4). Those who may have a disadvantageous 
Fig. 4  Schematic representation 
of typical age- and sex-related 
loss of BMD in women and the 
effect of physical activity and 
genetics
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levels of PA
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Fig. 3  Schematic representation 
of typical age- and sex-related 
loss of BMD in men and the 
effect of physical activity and 
genetics
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39European Journal of Applied Physiology (2019) 119:29–47 
1 3
genetic predisposition, however, but complete sufficient 
weight-bearing activity to produce a substantial osteogenic 
response may be able to combat their negative genetic pre-
disposition resulting in increased BMD, as evidenced in 
children (Mitchell et al. 2016) (Advantageous TGS or high 
levels of PA). Similarly, those who do not complete suitable 
levels of activity but possess an advantageous genetic profile 
may also present with moderate BMD (Advantageous TGS 
or high levels of PA). Those with an advantageous genetic 
profile who also complete large volumes of weight-bearing 
physical activity are likely to have the highest BMD (Advan-
tageous TGS and high levels of PA), which could be induced 
from a gene–physical activity interaction.
In the case of a gene–physical activity interaction, a hypo-
thetical relationship between genetics, physical activity and 
the resultant BMD is presented below (Fig. 5). Each bar 
represents a different individual and a hypothetical scenario 
for BMD ranging from a low BMD to a high BMD (the bar 
colour indicates BMD at any given level of physical activ-
ity in Figs. 5, 6). BMD is dependent on both genetics and 
physical activity level, so as physical activity level increases, 
BMD is enhanced for every individual regardless of their 
BMD before this increase in physical activity occurred. 
The magnitude of increase in BMD and maximum BMD 
level attained, however, are under the influence of genetics 
(Ralston and Uitterlinden 2010). Consequently, those with 
a more advantageous genetic predisposition, indicated by a 
higher total genotype score (TGS), combined with a higher 
volume of mechanical loading are more likely to reach a 
higher BMD than those with a disadvantageous genetic pre-
disposition and/or a lower volume of mechanical loading, 
assuming all else is equal.
It is possible, however, that a linear relationship between 
physical activity dose and BMD response does not exist at 
the extremes of physical activity (PA). National Health and 
Nutrition Examination Survey (NHANES) data have previ-
ously demonstrated that BMD did not differ between males 
who reported completing four–six times more physical activ-
ity than the recommended guidelines (Whitfield et al. 2015). 
The physical activity and BMD relationship is still poorly 
understood and in the case of endurance runners, overtrain-
ing can negatively affect BMD (Fig. 6) due to the associated 
influence of energy availability. Other factors such as the 
type of activity and dietary intake, however, are also impor-
tant in regard to the bone adaptation as discussed in “BMD 
in athletic populations” and would consequently affect this 
relationship.
Genetic association with BMD in athletic 
populations
In 212 young males, significantly higher total body BMD in 
84 weight-bearing athletes than 80 controls was observed in 
the FF (7.7%) and Ff (6.9%) but not ff (1.8%) genotypes of 
the VDR FokI rs2228570 polymorphism, whilst significantly 
lower total BMD was only observed in the FF (− 4.5%) gen-
otype when comparing 48 swimmers with a control group 
(Nakamura et al. 2002b). This suggests that individuals with 
the FF genotype may be more responsive to mechanical 
loading, resulting in greater BMD when that environmen-
tal factor is prominent. This notion was further reinforced 
in 44 Japanese track and field athletes, where higher bone 
volume was expressed in those with the FF genotype, but 
not in those with the Ff genotype (Nakamura et al. 2002a). 
Fig. 5  Schematic hypotheti-
cal representation of the BMD 
outcome for different individu-
als representing variable genetic 
profiles (TGS) and levels of 
physical activity
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40 European Journal of Applied Physiology (2019) 119:29–47
1 3
This particular polymorphism, Fokl (rs2228570), exhib-
its a C to T transition that creates an upstream initiation 
codon, leading to the production of VDR proteins that are 
three more amino acids in length. The F allele codes for the 
absence of the restriction, whilst the f allele codes for the 
presence of the initiation codon, which leads to the longer 
amino acid length (Gross et al. 1996; Ames et al. 1999). It 
is suggested that the F variant shows greater transactivation 
(protein expression) than the f variant and this increased bio-
logical activity (and associated increased intestinal absorp-
tion of calcium) could explain why higher BMD has been 
reported in those with the FF genotype (Arai et al. 1997; 
Colin et al. 2000; Uitterlinden et al. 2004; Ames et al. 1999) 
as detailed below (Fig. 7). VDR controls the transcription 
of other genes including bone gamma-carboxyglutamate 
protein/osteocalcin (BGLAP) that are instrumental for this 
calcium absorption and bone formation (Moran et al. 2014). 
A direct effect of osteoblastic/osteocytic VDR signalling 
on bone remodelling has also been proposed, although spe-
cific understanding of this notion is still lacking and largely 
depends on calcium balance (Lieben and Carmeliet 2013).
The potential association of VDR with BMD and/or frac-
ture has also been supported across a number of different 
SNPs (rs1544410, rs7975232 and rs731236) in various 
cohorts, such as pre- and postmenopausal women (Riggs 
et al. 1995; Horst-Sikorska et al. 2007; Ji et al. 2010; Maro-
zik et al. 2013). However, contradictory results have also 
been reported across these cohorts (Horst-Sikorska et al. 
2013; Moran et al. 2015; Castelán-Martínez et al. 2015; 
Dabirnia et al. 2016). The highly conflicting nature of the 
findings may be due to not adjusting for covariates (e.g. 
Fig. 6  Schematic hypotheti-
cal representation of the BMD 
outcome for different indi-
viduals (e.g. endurance runners) 
representing variable genetic 
profiles (TGS) and levels of 
physical activity
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Fig. 7  VDR rs2228570 FF genotype and the associated pathways leading to enhanced BMD
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BMI) as well as the different ethnic groups, sample sizes 
and study designs utilised (Xu et al. 2005).
A recent study of 99 elite academy footballers found 
a number of SNPs associated with bone phenotypes (tra-
becular density, cortical thickness and cross sectional area) 
using pQCT analysis. However, these associations were only 
observed before, but not after, a 12-week period of increased 
football training volume and thus no association between 
genotype and changes in bone parameters over time was 
observed. These variants included SOST rs1877632, P2RX7 
rs1718119, P2RX7 rs3751143 as well as TNFRSF11A 
(RANK), TNFSF11 (RANKL) and TNFRSF11B (OPG) 
SNPs rs9594738, rs1021188 and rs9594759 (Varley et al. 
2018). Although no genotype–training interactions were 
observed for the SNPs analysed in this investigation, other 
candidate genes could be sensitive to physical loading (i.e. 
gene–environment interaction) and thus modulate athlete 
health (and, by extension, enhance endurance performance). 
Specifically, if an athlete has a genetic predisposition 
towards low BMD or elevated risk of stress fracture, exer-
cise training and/or diet could be modified to accommodate.
Genetic association with stress fracture injury
There is a lack of conclusive evidence regarding external 
determinants of stress fractures (Wright et  al. 2015) as 
mentioned in “BMD, elite athletes and injury risk”. In more 
recent times, the idea of a proposed genetic influence has 
been investigated primarily in military recruits, due to the 
abrupt increase in training, large training volumes and high 
prevalence of stress fractures (Lappe et al. 2008). Examples 
have included the calcitonin receptor (CTR ) rs1801197 and 
LRP5 rs2277268 polymorphisms, which were associated 
with femoral neck stress fractures in 72 Finnish military 
recruits (Korvala et al. 2010). Participants who possessed 
the CTR C allele together with a VDR C-A haplotype were 
more protected from stress fractures, which may be due to 
the role of CTR in osteoclast-mediated bone resorption (Pon-
del 2000).
Furthermore, larger sized CAG androgen receptor (AR) 
gene repeats (> 16) were more common in Israeli military 
personnel who had suffered stress fractures (23%) than those 
who had not suffered this injury (13%) (Yanovich et al. 
2011). A higher number of CAG repeats within the AR gene 
are inversely associated with the transcriptional response to 
testosterone (Zitzmann et al. 2001) and deficiency in such 
hormones could influence bone metabolism and potential 
bone loss (Mohamad et al. 2016; Khosla 2015).
Stress fracture susceptibility, in relation to genetics, has 
also been investigated in athletes for the first time recently, 
with findings suggesting that athletes with specific genetic 
variants may have an increased vulnerability to this injury 
(Varley et al. 2015, 2016, 2017). Interestingly, three of the 
same SNPs (VDR FokI rs2228570, TNFSF11 rs1021188 
and the loss of function P2RX7 rs3751143) as mentioned 
above, alongside TNFRSF11A rs3018362, were associated 
with stress fracture incidence in the Stress Fracture in Elite 
Athlete (SFEA) cohort. However, a gain of function P2RX7 
SNP (rs1718119) was associated with multiple stress frac-
ture occurrence. Functional expression of purinergic recep-
tor P2X7 primarily regulates configuration of osteoclasts 
(Agrawal et al. 2010), as well as augmenting bone formation 
via a cell-autonomous role that leads to stimulation of min-
eralisation (Panupinthu et al. 2008), which may explain why 
some P2RX7 polymorphisms have also been associated with 
low baseline and accelerated bone loss in post-menopausal 
women (Gartland et al. 2012). P2RX7 is a particularly inter-
esting candidate gene in regard to potential gene–physical 
activity interactions and outcomes for BMD. Mice with a 
null mutation of P2RX7 have been reported to show > 73% 
reduced sensitivity to mechanical loading (Li et al. 2005). 
Fluid shear stress increased prostaglandin (PG)E2 release in 
wild-type osteoblast cells but had no effect on  PGE2 release 
in knockout osteoblast cells.  PGE2 administration activates 
cortical bone modelling resulting in increased bone mass 
(Jee et al. 1990) and Li et al. (2005) suggested that these 
findings indicate ATP signalling through P2RX7 is impor-
tant for mechanically induced release of prostaglandins by 
bone cells and subsequent bone formation. Consequently, 
variation in P2RX7 SNPs such as rs3751143 could result in 
differing responses to mechanical loading and alterations to 
BMD, potentially influencing stress fracture susceptibility.
Although research investigating genetic influence on 
stress fracture has begun using the SFEA cohort, this 
was a loosely defined group, which comprised athletes of 
mixed abilities and from a range of sports. A more focussed 
approach, which removes the variability (i.e. loading/train-
ing patterns) introduced by incorporating athletes from dif-
ferent sports into one investigation, would be advantageous.
Future directions and conclusions
There are numerous polymorphisms that need further 
exploration vis-à-vis BMD. In particular, gene–environ-
ment (i.e. gene–physical activity) interactions are likely 
to contribute substantially to inter-individual differences 
in BMD throughout the human lifespan. Exciting findings 
have been observed in regard to gene–physical activity 
interactions and genetic associations with stress fracture, 
particularly in variants of pathways involved in the adap-
tation of bone to mechanical loading, such as the RANK/
RANKL/OPG system.
Therefore, the study of specific cohorts, who experi-
ence unusually high mechanical loads and who may dis-
play unusual bone phenotypes and/or possess genetic 
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characteristics that differ from the norm, may provide 
novel insight into the area. Such individuals include elite 
athletes, who are at the extremes of human physiologi-
cal capability, experience much greater environmental 
(mechanical) stress than most and might possess a geno-
type particularly suitable to tolerate those stresses.
GWAS or ideally whole genome sequencing (WGS) 
studies using athletic populations with their differentiating 
extreme phenotypes are, in principle, the next logical steps 
to identify key polymorphisms. Detailed study of gene 
function can follow. However, most GWAS designs cannot 
account for gene–gene/gene–environment interactions and 
only analyse SNPs with minor allele frequencies of more 
than 1%, not rare variants that may lie between 0.1–1% or 
even lower. Thus, GWAS is appropriate for the discovery 
of common variants that may confer low/moderate risk 
but are underpowered for the detection of rare variants, 
which may have a large influence on a complex phenotype 
according to the common disease/rare variant hypothesis 
(Li and Leal 2008). Conducting GWAS or WGS studies is 
also extremely challenging due to the associated costs and 
difficulty in recruiting sufficiently large numbers of such 
a specific population. Even a panel of SNPs for investiga-
tion that is far lower in number than used in contemporary 
GWAS, for example, 500 SNPs, would require a sample 
size of 1200 to detect an effect size of 0.02 in a continu-
ous trait, assuming 80% statistical power, a minor allele 
frequency of 20% and an alpha level of 0.0001. Approxi-
mately the same size of sample would be needed for each 
group of a case–control study design, assuming the same 
parameters and an effect size (odds ratio) of up to 1.4 
(Bouchard 2011).
While the large cohorts necessary for GWAS and even-
tually WGS studies of BMD in athletes are built, smaller 
samples (steps towards building the bigger sample) can be 
used to test hypotheses about genetic variants emerging 
from GWAS in relevant clinical populations. Assessing 
bone and injury phenotype data in those athletes will also 
enhance understanding of any observed genotype–pheno-
type relationship (Wang et al. 2013). A relatively homog-
enous group of athletes who experience high mechanical 
loads on some bone structures, such as endurance runners, 
would be suitable for this kind of investigation. Specifi-
cally, measuring areal BMD via DEXA scanning, with a 
particular emphasis on the primary loading sites in this 
population, would probably provide appropriate data to 
combat some of the challenges identified in this review. 
It would be fascinating to discover whether those athletes 
have a genotype that enhances BMD, protects against the 
effects of the large volume of training required and reduces 
risk of stress fracture. One preliminary report (using just 
14 participants) even documents an attempt to reduce the 
risk of tendon, ligament and bone injuries by modifying 
athlete training programmes based upon genetic charac-
teristics (Goodlin et al. 2015). This illustrates the kinds 
of future applications possible in this field after the more 
fundamental research has been conducted successfully.
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